Related Experiment Videos
HIV: effectiveness of complementary and alternative medicine
Rachel Power1, Cheryl Gore-Felton, Mark Vosvick
1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Rd., Stanford, CA 94305-5718, USA. rpower@leland.stanford.edu
Primary Care
|October 24, 2002
Summary
Complementary and alternative medicine (CAM) shows promise for people with HIV-AIDS, but more research is needed. Larger, diverse studies are essential to confirm the safety and efficacy of CAM interventions.
Area of Science:
- Integrative Medicine
- Public Health
- Clinical Research
Background:
- Studies on complementary and alternative medicine (CAM) for HIV-AIDS often have small sample sizes and limited follow-up, hindering generalizability.
- Participant attrition due to study demands and illness burden is a significant challenge in clinical research with chronically ill populations.
- Existing scientifically sound studies show promising results, highlighting the need for further investigation.
Purpose of the Study:
- To underscore the urgent need for more robust, empirically based research on CAM for individuals living with HIV-AIDS.
- To emphasize the necessity of understanding the health benefits, risks, toxicities, and interactions of CAM used alongside conventional HIV treatments.
- To advocate for larger, diverse, and longitudinal studies to accurately assess CAM's safety and efficacy.
Main Methods:
- Review of existing outcome studies on CAM efficacy in people with HIV-AIDS.
- Identification of limitations in current research, including small sample sizes, participant attrition, and lack of long-term data.
- Analysis of the need for prospective, randomized, controlled trials with larger, diverse populations.
Main Results:
- Many studies report trends suggesting CAM benefits but lack statistical significance due to small sample sizes.
- A high prevalence of alternative supplement use in conjunction with HIV medication is observed.
- Current evidence suggests CAM may improve quality of life, but safety and efficacy require further rigorous evaluation.
Conclusions:
- Larger sample sizes and longitudinal, controlled designs are crucial for determining the scientific merit, safety, and efficacy of CAM in HIV-AIDS management.
- Clinicians must assess CAM use, as patients may not disclose usage or understand potential risks and contraindications.
- Future research must include ethnically diverse and gender-balanced populations to ensure findings are applicable to the evolving HIV epidemic.